Rarity Bioscience: Funding, Investors & Team (Sep 2026)
In order to find uncommon nucleic acid sequences in biological samples such liquid biopsies for research, pharma, and clinic, Rarity Bioscience offers ultrasensitive multiplex assays. Rarity SafeLock, the technology platform we use, allows read-out based on flow cytometry and already installed instruments. A discovery made by Dr. Lei Chen, a molecular biologist with a Doctorate who worked with Professor Ulf Landegren's team at the Department of Immunology, Genomics, and Pathology at Uppsala University, led to the establishment of the company in 2021.
Rarity Bioscience has raised $540k across 1 funding round on record, the most recent a Seed of $540k announced in Feb 2023.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Rarity Bioscience Company Profile and Key Stats
Latest funding round on record: Feb 2023.
Rarity Bioscience Funding Rounds
Rarity Bioscience Founders and Leadership Team
No contact details are on record for this team yet.
Rarity Bioscience Funding Compared to Other Biotechnology Startups
Rarity Bioscience's latest round of $540k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Rarity Bioscience in Biotechnology and Uppsala
Companies Similar to Rarity Bioscience
Pixelgen Technologies, established in Sweden in 2020, focuses on the advancement of biomedical research and…
Oblique Therapeutics is developing a new type of antibody-based medication for chronic pain and metastatic…
Emulsi Biotech is a biotechnology company that develops lipid technology to deliver biologic drugs orally.
Our vision is to develop and bring to the market safe and effective treatments for women specific diseases…
OncoZenge is a Swedish pharmaceutical company. It develops better products for the supportive care of cancer…
Elicera Therapeutics is a clinical stage immuno-oncology company developing cell and gene therapies for…
Alligator Bioscience is an innovative research based biotech company focused on developing novel drugs for…
Moleculent is dedicated to creating tech-based products that utilize fresh knowledge about the molecular…
Bio-Works was established in 2006 and specializes in creating, producing, and distributing cutting-edge…
Verigraft AB is a biotech company that creates personalized tissue-engineered transplants for use in…
Lipum aims to eliminate or alleviate painful symptoms for millions of patients suffering from chronic…
ArgusEye is a biotech firm that offers sensor solutions for instant identification of biological systems and…
Rarity Bioscience Funding FAQs
What does Rarity Bioscience do?
In order to find uncommon nucleic acid sequences in biological samples such liquid biopsies for research, pharma, and clinic, Rarity Bioscience offers ultrasensitive multiplex assays. Rarity SafeLock, the technology platform we use, allows read-out based on flow cytometry and already installed instruments. A discovery made by Dr. Lei Chen, a molecular biologist with a Doctorate who worked with Professor Ulf Landegren's team at the Department of Immunology, Genomics, and Pathology at Uppsala University, led to the establishment of the company in 2021.
How much funding has Rarity Bioscience raised?
Rarity Bioscience has raised $540k across 1 round on record. The most recent is a Seed of $540k announced in Feb 2023.
When did Rarity Bioscience last raise funding?
Rarity Bioscience's most recent funding round on record is a Seed of $540k, announced in Feb 2023.
Who is the CEO of Rarity Bioscience?
Linus Bosaeus is listed as CEO at Rarity Bioscience.
Where is Rarity Bioscience headquartered?
Rarity Bioscience is based in Uppsala, Uppsala Lan, Sweden.
How many employees does Rarity Bioscience have?
Rarity Bioscience is in the 1-10 employee band.
How does Rarity Bioscience's funding compare to other Biotechnology startups?
Rarity Bioscience's latest round of $540k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Rarity Bioscience Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Rarity Bioscience is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.